Best Healthcare & Big Pharma
Stocks in 2026

The Healthcare & Big Pharma category comprises global pharmaceutical leaders, medical device manufacturers and diagnostics firms that play a key role in supporting health systems worldwide. These companies benefit from strong pricing power (patented treatments), robust R&D pipelines and rising demand driven by aging populations, chronic diseases as well as expanding access to care. However, the industry is currently facing a major patent cliff, with many top-selling drugs losing exclusivity by 2035, opening the door to competition from generics and biosimilars. This increases the pressure to innovate and diversify through new drug development, M&A acquisitions, partnerships and next-generation therapies.